Barr Ellison Solicitors – commercial property
Advertisement EY mid banner
Advertisement: TTP
ARM Innovation Hub
RealVNC mid banner careers
Advertisement: Cambridge Network
Advertisement: RSM
RealVNC mid-banner general
Advertisement: Wild Knight Vodka
Advertisement: Mogrify
Mid banner advertisement: BDO
Advertisement: Cambridge Corporate Finance Club
Advertisement: Innova Systems
Advertisement: EBCam mid banner
28 January, 2015 - 10:33 By News Desk

Targeted anti-cancer drug delivery system

Enterprise Europe Network TOSI20150107001

A Slovenian research institution has developed a molecular system for delivery of anti-cancer drugs specifically to target sites, by using cathepsin inhibitors as guides towards cathepsins released by tumour cells.

The system prevents toxic side effects, reduces the dosage, and treatment costs. The researchers seek investment, technical cooperation, and/or joint venture partnership, with partners with the capacity to fund and/or carry out pre-clinical studies and to scale up the production.

Closing date: 12/01/2016REF: TOSI20150107001

Add new comment

Newsletter Subscription

Stay informed of the latest news and features